4.4 Review

Malignant intraventricular meningioma: literature review and case report

Journal

NEUROSURGICAL REVIEW
Volume 45, Issue 1, Pages 151-166

Publisher

SPRINGER
DOI: 10.1007/s10143-021-01585-3

Keywords

Intraventricular malignant meningioma; Lateral ventricle; Third ventricle; Papillary meningioma; Rhabdoid meningioma

Ask authors/readers for more resources

Malignant intraventricular meningiomas are rare, mainly affecting women and located in the lateral ventricle and trigonal region. They are characterized by irregular borders, heterogeneous enhancement, and perilesional edema. The histology is predominantly anaplastic, with a high rate of CSF spread and poor prognosis.
Malignant intraventricular meningiomas (IVMs) are very rare with only a few reported cases. A midline search up to December 2020 selected 40 articles for a total of 65 patients. The inclusion criteria were series and case reports in English language, as well as papers written in other languages, but with abstracts written in English. Malignant IVMs at the first diagnosis (group A, 50 patients) and those with anaplastic transformation from previous WHO grades I and II tumors (group B, 15 patients) were separately analyzed. The unique personal case among 1285 meningiomas (0.078%) is also added. Malignant IVMs mainly occur in women (61%) with a median age of 45 years and are mainly located in the lateral ventricle (93%) and trigonal region (74%), with no cases in the fourth ventricle. Irregular borders (80%), heterogeneous enhancement (83%), and perilesional edema (76%) are the most frequent radiological findings. The histology was mainly pure anaplastic (85%), whereas papillary (7%), rhabdoid (5%), and mixed forms (3%) are very rare. The CSF spread was found in 60% of the cases. The prognosis is very dismal, with an overall median survival of 17.5 months after surgery for the anaplastic forms. Malignant IVMs at initial diagnosis (group A) show better overall survival (25 months) than those occurring from anaplastic transformation of lower grade tumors (group B) (10.1 months).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available